>AT4G25020.1 |  KOW domain-containing protein / D111/G-patch domain-containing protein 
MKLSFSLPPKSKSRVSLNSDRKDCIGAGNLKQFVTEFDPSETLTDSKPKYVIPPIEDRRR 
SYRSIDLPLPSASGLQFEAEIPSGDGSDNNITYGLNLRQKVENVEKPEPVEKMLLKSMRT 
DLESLPDAPEKEDFESFPVDGFGEALLAGYGWKPGQGIGLKAKEDVKIVEYEKWSGNEGF 
GFGKSDKAMKMIDNKLVGSGSHEEVKVGINKIENMEKDRVVRKRNRETEGESRTEVKACK 
QNYRGQTRETREKTSWLRSHIKVRIISKDVKGGRLYLKKAVVTDVVGPTSCDIAMDETQE 
LVQGIDQELLETALPRRGGSVLVLSGRHKGVYGRLVEKDLDKETGVVCDADSQEMLHVKL 
DQVAEYIGDPADIGY*
>AT4G16680.1 |  RNA helicase putative 
METNVPEKKILGFPEEMNSTIQFLSVEKTTCRLPVSIKFNIPKKISTKRRRISVEEEEEE 
EDENKTKLSSWEKVLSSDEILRLREVSRRKYLTDRENKKVEELRDERKDDDDVEGYRFPD 
AYDQEGCIDQKKRFDVAKERYCERRRSGRVVTEQEAWEDHQAQKARVRFGAKDKKQVVDG 
YEFVFDDLTGFVEESSEAETGKHRGCYSKTAAEKAREGREFLPIHGYREELLKLIEENQV 
LVIVGETGSGKTTQIPQYLQEAGYTKRGKIGCTQPRRVAAMSVASRVAQEVGVKLGHEVG 
YSIRFEDCTSEKTVIKYMTDGMLLRELLIEPKLDSYSVIIIDEAHERTLSTDILFALVKD 
VAKVRPDLRLIISSATLEAKKFSEYFDSARIYLIPGRRYPVEKLFRKCPEPDYLETVIRT 
VVQIHQTEAIGDILVFLTGQEEIETVETNLKRRMMDLGTKGSEIIICPIYSNLPTPLQAK 
VFEPAPKGTRKVVLATNIAETSLTIDGVKYVIDPGYCKINSYNPRTGMESLLVTPISKAS 
AAQRAGRSGRTGPGKCFRLYNIKDLEPTTIPEIQRANLASVVLTLKSLGIQDVFNFDFMD 
PPPENALLKALELLYALGALDEIGEITKVGERMVEFPVDPMLSKMIVGSEKYKCSKEIIT 
IAAMLSVGNSVFYRPKNQQVFADKARMDFYEDTENVGDHIALLRVYNSWKEENYSTQWCC 
EKFIQSKSMKRARDIRDQLLGLLNKIGVELTSNPNDLDAIKKAILAGFFPHSAKLQKNGS 
YRRVKEPQTVYVHPNSGLFGASPSKWLVYHELVLTTKEYMRHTTEMKPEWLIEIAPHYYK 
LKDIEDTRPKKTQRRIEEASTSKVDTNKKTRTSKVDTNKKSKR*
>AT1G32490.1 |  ESP3 (ENHANCED SILENCING PHENOTYPE 3) ATP binding / ATP-dependent RNA helicase/ ATP-dependent helicase/ helicase/ nucleic acid binding 
MASNDLKTWVSDKLMMLLGYSQAAVVNYLIAMAKKTKSPTELVGELVDYGFSSSGDTRSF 
AEEIFARVPRKTAGVNLYQKHEAEAAMLVRKQKTYALLDADDDEDEVVVEKKSSVSESRK 
SDKGKKRFRKKSGQSDESDGEVAVREDSRHVRRKVSEEDDGSESEEERVRDQKEREELEQ 
HLKDRDTARTRKLTEQTLSKKEKEEAVRRANALEKDDLYSLRKVSRQEYLKKREQKKLDE 
LRDEIEDEQYLFGGEKLTETELREFRYKKELYDLVKKRTQDEDNVEEYRIPDAYDQEGGV 
DQEKRFSVAVQRYRDLDSTEKMNPFAEQEAWEDHQIGKATLKFGAKNKQASDDYQFVFED 
QINFIKESVMAGENYEDAMDAKQKSQDLAEKTALEELQEVRRSLPIYTYRDQLLKAVEEH 
QVLVIVGDTGSGKTTQIPQYLHEAGYTKRGKVGCTQPRRVAAMSVAARVAQEMGVKLGHE 
VGYSIRFEDCTSDKTVLKYMTDGMLLRELLGEPDLASYSVVIVDEAHERTLSTDILFGLV 
KDIARFRPDLKLLISSATMDAEKFSDYFDTAPIFSFPGRRYPVEINYTSAPEADYMDAAI 
VTILTIHVREPLGDILVFFTGQEEIETAEEILKHRIRGLGTKIRELIICPIYANLPSELQ 
AKIFEPTPEGARKVVLATNIAETSLTIDGIKYVVDPGFSKMKSYNPRTGMESLLITPISK 
ASATQRAGRAGRTSPGKCYRLYTAFNYNNDLEENTVPEVQRTNLASVVLALKSLGIHDLI 
NFDFMDPPPAEALVKSLELLFALGALNKLGELTKAGRRMAEFPLDPMLSKMIVVSDKYKC 
SDEIISIAAMLSIGGSIFYRPKDKQVHADNARMNFHTGNVGDHIALLKVYSSWKETNFST 
QWCYENYIQVRSMKRARDIRDQLEGLLERVEIDISSNLNELDSVRKSIVAGFFPHTAKLQ 
KNGSYRTVKHPQTVHIHPNSGLSQVLPRWVVYHELVLTSKEYMRQVTELKPEWLIELAPH 
YYQLKDVEDAASKKMPKGAGKAAM*
>AT1G13800.1 |  pentatricopeptide (PPR) repeat-containing protein 
MRVFPIPLLSHVRGLIRQGPSSRFYVVPALARTNLTISHSEQVKEGTFDYKALELNDIGV 
LRVLNSMKDDPYLALSFLKRIEGNVTLPSVQAYATVIRIVCGWGLDKKLDTFLFELVRRG 
DEGRGFSVMDLLKAIGEMEQSLVLLIRVSTALVKAYANLDMFDEAIDIFFRAYYSLGRAP 
DIKALNFLISRMIASGRSDMVVGFFWEIERLGLDADAHTYVLVVQALWRNDDKEELEKLL 
SRLLISETRNPCVFYLNFIEGLCLNQMTDIAYFLLQPLRDANILVDKSDLGIAYRKVVRG 
LCYEMRIEDAESVVLDMEKHGIDPDVYVYSAIIEGHRKNMNIPKAVDVFNKMLKKRKRIN 
CVIVSSILQCYCQMGNFSEAYDLFKEFRETNISLDRVCYNVAFDALGKLGKVEEAIELFR 
EMTGKGIAPDVINYTTLIGGCCLQGKCSDAFDLMIEMDGTGKTPDIVIYNVLAGGLATNG 
LAQEAFETLKMMENRGVKPTYVTHNMVIEGLIDAGELDKAEAFYESLEHKSRENDASMVK 
GFCAAGCLDHAFERFIRLEFPLPKSVYFTLFTSLCAEKDYISKAQDLLDRMWKLGVEPEK 
SMYGKLIGAWCRVNNVRKAREFFEILVTKKIVPDLFTYTIMINTYCRLNEPKQAYALFED 
MKRRDVKPDVVTYSVLLNSDPELDMKREMEAFDVIPDVVYYTIMINRYCHLNDLKKVYAL 
FKDMKRREIVPDVVTYTVLLKNKPERNLSREMKAFDVKPDVFYYTVLIDWQCKIGDLGEA 
KRIFDQMIESGVDPDAAPYTALIACCCKMGYLKEAKMIFDRMIESGVKPDVVPYTALIAG 
CCRNGFVLKAVKLVKEMLEKGIKPTKASLSAVHYAKLKAKGLR*